Akt inhibitor V triciribine CAS: 35943-35-2 is a small molecule inhibitor that targets the Akt signaling pathway. This pathway plays a key role in regulating cell survival, proliferation, and growth, making it an attractive target for cancer therapy.
Chemical Name:
Akt inhibitor V triciribine is also known as NSC154020 and TCN.
Molecular Formula:
The molecular formula of Akt inhibitor V triciribine is C13H16N6O4S.
Formula Weight:
The formula weight of Akt inhibitor V triciribine is 360.37 g/mol.
CAS No:
The CAS number of Akt inhibitor V triciribine is 35943-35-2.
Top Ten Keywords from Google and Synonyms:
Health Benefits of Akt Inhibitor V Triciribine:
Akt inhibitor V triciribine has shown potential health benefits due to its ability to inhibit the Akt signaling pathway. Some of the potential benefits of Akt inhibitor V triciribine include:
Potential Effects:
Akt inhibitor V triciribine can produce a range of effects depending on the dosage and individual response. Some of the potential effects of Akt inhibitor V triciribine include:
Product Mechanism:
Akt inhibitor V triciribine works by inhibiting the Akt signaling pathway, which plays a key role in regulating cell survival, proliferation, and growth. By blocking this pathway, Akt inhibitor V triciribine can induce apoptosis, or programmed cell death, and inhibit tumor growth.
Safety:
Akt inhibitor V triciribine can be safe when used appropriately and under medical supervision. However, it can cause adverse effects if misused or abused. Some of the potential side effects of Akt inhibitor V triciribine include:
Gastrointestinal Disturbances: Akt inhibitor V triciribine may cause gastrointestinal disturbances such as nausea and vomiting.
Liver Toxicity: Akt inhibitor V triciribine may cause liver toxicity in some individuals.
Dosing Information:
The appropriate dose of Akt inhibitor V triciribine depends on several factors such as age, weight, and health status. It is essential to follow dosing instructions carefully and only use Akt inhibitor V triciribine under medical supervision.
Conclusion:
Akt inhibitor V triciribine is a small molecule inhibitor that targets the Akt signaling pathway. It has shown potential as a cancer treatment due to its ability to inhibit cell survival and proliferation. While Akt inhibitor V triciribine may provide some health benefits, it should only be used under medical supervision and with caution due to its potential side effects. Additionally, more research is needed to fully understand its safety and efficacy in humans